ENDRA Life Sciences Inc.

NDRA

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-092253
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Tokman Alexander Y (CEO)
SEC Filing link

Summary

Type

Neutral

Net shares

+26,921

% of shares

35.89%

Amount (USD)

$0

Insider confidence score

90.0 out of 100

Positive

  • Massive buy (≥10% of shares)

Negative

  • Minimal buy amount (<$10K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Grant

Date

2026-03-02

Code

A

Net shares

+26,921.0

Acquired/Disposed

Acquired

Shares Owned Before

75,005.0

Shares Owned After

101,926.0

Filing's footnotes

1. Holdings include unvested restricted stock units (&quot;RSUs&quot;).

2. Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.